Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs?

MLA

Anastasi, Carole, et al. “Are 5’-O-Carbamate-2’,3’-Dideoxythiacytidine New Anti-HIV and Anti-HBV Nucleoside Drugs or Prodrugs?” Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 15, Aug. 2003, pp. 2459–63. EBSCOhost, https://doi.org/10.1016/s0960-894x(03)00496-7.

APA

Anastasi, C., Vlieghe, P., Hantz, O., Schorr, O., Pannecouque, C., Witvrouw, M., De Clercq, E., Clayette, P., Dereuddre-Bosquet, N., Dormont, D., Gondois-Rey, F., Hirsch, I., & Kraus, J.-L. (2003). Are 5’-O-carbamate-2’,3’-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs? Bioorganic & Medicinal Chemistry Letters, 13(15), 2459–2463. https://doi.org/10.1016/s0960-894x(03)00496-7

Chicago

Anastasi, Carole, Patrick Vlieghe, Olivier Hantz, Olivier Schorr, Christophe Pannecouque, Myriam Witvrouw, Erik De Clercq, et al. 2003. “Are 5’-O-Carbamate-2’,3’-Dideoxythiacytidine New Anti-HIV and Anti-HBV Nucleoside Drugs or Prodrugs?” Bioorganic & Medicinal Chemistry Letters 13 (15): 2459–63. doi:10.1016/s0960-894x(03)00496-7.